laSexta, through its corporate responsibility initiative launched in partnership with the AXA Foundation, presented the Constantes y Vitales Awards for…
Josep Tabernero
A delegation from Charité University Hospital Berlin, led by Dominik Modest, Director of the Charité Comprehensive Cancer Center, has visited…
“Bringing the finish line closer” is the slogan of the 12th edition of the Cities Against Pancreatic Cancer Race, organised…
Vall d’Hebron Institute of Oncology (VHIO) celebrated its 20th anniversary yesterday with an institutional event at Barcelona’s Llotja de Mar,…
In the two decades since its official establishment in 2006, the Vall d’Hebron Institute of Oncology (VHIO) has established itself…
Results of final overall survival analysis from the global, randomized phase 3 MATTERHORN clinical trial show that adding perioperative durvalumab…
The HERIZON-GEA-01 open-label, phase 3 clinical trial was designed to compare first-line treatment with the bispecific antibody zanidatamab plus chemotherapy…
Today, March 31, marks World Colorectal Cancer Day, an occasion to raise awareness about one of the most common cancers…
This year, Vall d’Hebron Barcelona Hospital Campus commemorated World Cancer Day with a public talk at Palau Robert, coinciding with…
The BREAKWATER open-label, randomized phase 3 study was designed to evaluate first-line treatment with targeted therapies encorafenib and cetuximab plus…
